• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms.

作者信息

Norman R W, Nickel J C, Fish D, Pickett S N

机构信息

Department of Urology, Dalhousie University, Halifax, Nova Scotia, Canada.

出版信息

Br J Urol. 1994 Nov;74(5):542-50. doi: 10.1111/j.1464-410x.1994.tb09181.x.

DOI:10.1111/j.1464-410x.1994.tb09181.x
PMID:7530115
Abstract

OBJECTIVES

To determine the prevalence of symptoms associated with benign prostatic hyperplasia (BPH) in Canadian men, and to establish whether the traditional separation of these symptoms into obstructive and irritative categories is valid.

SUBJECTS AND METHODS

A probability sample of 508 Canadian men 50 years of age or older was surveyed by telephone. The survey questions and scoring system used were devised to allow estimation of symptom prevalence and were based on the frequency and severity of the symptoms. Using the data from respondents who had moderate to severe symptoms, a cluster analysis was utilized to analyse relationships among symptoms.

RESULTS

The most prevalent symptoms were nocturia (63%), weak stream (61%) and urinary frequency (46%). Urgency was reported by 18%, a sense of incomplete bladder emptying by 23%, intermittency by 18% and hesitancy by 13%. Using predefined cutoff scores, 23% of the respondents experienced moderate to severe symptoms associated with BPH; the prevalence of moderate to severe symptoms increased with age. The clusters were grouped on the basis of the symptoms driving them, with one cluster designated as 'moderates', two clusters designated as 'irritatives' and two designated as 'obstructives'. The moderates cluster was driven by respondents who had lower symptom scores evenly distributed across all symptoms. The irritatives and obstructives clusters were driven by respondents with higher scores for symptoms considered by convention to be irritative or obstructive in nature and, thus, were designated accordingly. Not all symptoms were discriminatory for irritative and obstructive symptom domains.

CONCLUSIONS

A large percentage of Canadian men 50 years of age or older experience symptoms commonly associated with BPH. The theoretical concept of irritative and obstructive symptom domains was supported partially by the cluster analysis. A clear typology of men with BPH symptoms could prove useful if treatments were found to be more effective for certain types of BPH symptoms. Thus these observations warrant further investigation into the differential effects of management approaches for BPH symptoms according to symptom clusters.

摘要

相似文献

1
'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms.
Br J Urol. 1994 Nov;74(5):542-50. doi: 10.1111/j.1464-410x.1994.tb09181.x.
2
Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK.英国一项基于社区的男性调查中,下尿路症状和自我报告诊断的“良性前列腺增生”的患病率及其对生活质量的影响。
BJU Int. 1999 Mar;83(4):410-5. doi: 10.1046/j.1464-410x.1999.00966.x.
3
Urinary symptoms in the community: how bothersome are they?社区中的泌尿系统症状:它们有多困扰人?
Br J Urol. 1994 Nov;74(5):551-5. doi: 10.1111/j.1464-410x.1994.tb09182.x.
4
Impact of lower urinary tract symptoms on discomfort in men aged between 50 and 80 years.下尿路症状对50至80岁男性不适的影响。
Urol Int. 2010;84(4):424-9. doi: 10.1159/000304509. Epub 2010 Mar 26.
5
Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.良性前列腺增生中下尿路症状的患病率、困扰程度及其对生活质量的影响。
J Urol. 2001 Aug;166(2):563-8.
6
Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas.郑州农村地区 40 岁及以上男性良性前列腺增生和下尿路症状的患病率及遗传度。
Prostate. 2019 Feb;79(3):312-319. doi: 10.1002/pros.23737. Epub 2018 Nov 18.
7
The prevalence of prostatism: a population-based survey of urinary symptoms.
J Urol. 1993 Jul;150(1):85-9. doi: 10.1016/s0022-5347(17)35405-8.
8
Implications of the most bothersome prostatism symptom for clinical care and outcomes research.
J Am Geriatr Soc. 1995 Sep;43(9):985-92. doi: 10.1111/j.1532-5415.1995.tb05562.x.
9
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.良性前列腺增生(BPH)与前列腺炎:临床诊断为BPH的男性中射精疼痛的患病率
BJU Int. 2005 Mar;95(4):571-4. doi: 10.1111/j.1464-410X.2005.05341.x.
10
Examining lower urinary tract symptom constellations using cluster analysis.使用聚类分析检查下尿路症状群。
BJU Int. 2008 May;101(10):1267-73. doi: 10.1111/j.1464-410X.2008.07598.x. Epub 2008 Mar 11.

引用本文的文献

1
Eight Days of Water-Only Fasting Promotes Favorable Changes in the Functioning of the Urogenital System of Middle-Aged Healthy Men.仅饮水 8 天即可促进中年健康男性泌尿生殖系统功能的有利变化。
Nutrients. 2020 Dec 30;13(1):113. doi: 10.3390/nu13010113.
2
Technique considerations and complication management in transurethral resection of the prostate and photoselective vaporization of the prostate.经尿道前列腺切除术和选择性光汽化前列腺术的技术考量与并发症处理
Transl Androl Urol. 2017 Aug;6(4):695-703. doi: 10.21037/tau.2017.07.30.
3
The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis.
全球下尿路症状(良性前列腺增生症的提示)负担:系统评价和荟萃分析。
Sci Rep. 2017 Aug 11;7(1):7984. doi: 10.1038/s41598-017-06628-8.
4
Prevalence of erectile dysfunction in men over 40 years of age in Turkey: Results from the Turkish Society of Andrology Male Sexual Health Study Group.土耳其40岁以上男性勃起功能障碍的患病率:来自土耳其男科学会男性性健康研究组的结果。
Turk J Urol. 2017 Jun;43(2):122-129. doi: 10.5152/tud.2017.24886. Epub 2017 Jun 1.
5
Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial.枸橼酸西地那非联合坦索罗辛与坦索罗辛单药治疗良性前列腺增生引起的男性下尿路症状的疗效比较:一项随机、双盲、安慰剂对照试验
Arab J Urol. 2016 Dec 29;15(1):53-59. doi: 10.1016/j.aju.2016.11.001. eCollection 2017 Mar.
6
Medical management of benign prostatic hyperplasia: Results from a population-based study.良性前列腺增生的医学管理:一项基于人群的研究结果。
Can Urol Assoc J. 2016 Jan-Feb;10(1-2):55-9. doi: 10.5489/cuaj.3058.
7
A Meta-Analysis of Long- Versus Short-Acting Phosphodiesterase 5 Inhibitors: Comparing Combination Use With α-Blockers and α-Blocker Monotherapy for Lower Urinary Tract Symptoms and Erectile Dysfunction.长效与短效磷酸二酯酶5抑制剂的Meta分析:比较联合α受体阻滞剂与α受体阻滞剂单药治疗下尿路症状和勃起功能障碍的疗效
Int Neurourol J. 2015 Dec;19(4):237-45. doi: 10.5213/inj.2015.19.4.237. Epub 2015 Dec 28.
8
BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).良性前列腺增生:前列腺癌的一个迹象?前列腺癌与环境研究(PROtEuS)的结果
World J Urol. 2015 Dec;33(12):2063-9. doi: 10.1007/s00345-015-1546-z. Epub 2015 Apr 1.
9
Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada.在加拿大,度他雄胺与坦索罗辛固定剂量复方制剂与度他雄胺和坦索罗辛联合单药治疗良性前列腺增生患者的成本分析。
Can Urol Assoc J. 2014 Jan-Feb;8(1-2):E1-7. doi: 10.5489/cuaj.755.
10
Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trial.度他雄胺-坦索罗辛联合治疗有症状良性前列腺增生的成本效益:基于CombAT试验的加拿大模型
Can Urol Assoc J. 2013 May-Jun;7(5-6):E393-401. doi: 10.5489/cuaj.12131. Epub 2013 Jun 12.